Pharmaceutical Industry Articles & Reports - Page 45

This article explains how AI tools can validate regulatory dossiers, catch technical errors before submission, and minimize rework for emerging biotech companies. Updated with 2025-2026 developments including FDA's ELSA AI assistant, eCTD v4.0 validation updates, McKinsey benchmarks, and the latest Gemini 2.5 vs GPT-5 comparisons.

Updated for 2026, this article examines the unique financial challenges facing regional hospitals — including 46% operating at negative margins — and details the accounting practices, software solutions, and AI-driven automation essential for maintaining stability and compliance.

An overview of San Francisco Bay Area neuroscience firms, updated February 2026. Examines companies in neurotechnology, BCIs, and neuropharmacology, with latest clinical trial results, FDA developments, and funding milestones.

An overview of market access analytics covering its definition, scope, and role in helping pharmaceutical firms navigate complex payer reimbursement models. Updated for 2026 with IRA drug price negotiation impacts, agentic AI platforms, EU HTA harmonisation, and digital therapeutics reimbursement advances.

A comprehensive overview of AI in pharmacovigilance (updated Feb 2026), covering agentic AI, GenAI-driven case processing, signal detection, CIOMS WG XIV framework, FDA/EMA joint principles, EU AI Act implications, and the latest industry platforms.

Learn how WORM (Write Once, Read Many) storage ensures data immutability and integrity for electronic records in the highly regulated biotechnology industry. Updated for 2026 with the latest on EU GMP Annex 11 revisions, SEC 17a-4 audit-trail alternatives, cloud WORM advances, and ransomware defense strategies.

Learn to design, secure, and manage a HIPAA-compliant API. Updated for 2026 with the proposed Security Rule overhaul, mandatory encryption and MFA requirements, and current enforcement trends.

Examine the GPT-5 model family's technical capabilities, ChatGPT Health and ChatGPT for Healthcare launches, applications in life sciences and medicine, and the ethical and regulatory considerations for AI in healthcare. Updated February 2026.

Examines the key scientific journals and trade publications in the pharma and biotech industries, covering peer-review, access models, and target audience.

An educational guide to executing compliant pharmaceutical remarketing. Explores platform policies on Google, Meta, LinkedIn, and Reddit, plus data privacy. Updated for 2025-2026 with Meta's health-data restrictions, FDA enforcement escalation, Google policy changes, and HIPAA tracking updates.

Updated 2026 survey of global online degrees and certificates in AI for pharmaceutical science. Compare programs by level, curriculum, cost, and duration – including new offerings from UCSF, Yale, and LIU.

An overview of AI applications in the pharmaceutical sector, from generative AI to ML. Explains key IT management challenges like data, compliance, and security.

An overview of OpenAI's open-weight GPT-OSS models. Examine their technical specifications, benchmark performance, gpt-oss-safeguard safety models, and applications for reasoning in healthcare.

Examines how AI accelerates the pharmaceutical drug pipeline, reducing time to market. Updated for 2026 with the latest clinical milestones, FDA guidance, and industry developments including Insilico Medicine's Phase IIa results and the Recursion-Exscientia merger.

Examines RegTech adoption challenges for emerging biotechs, focusing on cost, scalability, and AI-driven compliance. Covers flexible licensing, usage-based pricing, deferred-value models, and the latest platform innovations from Veeva Vault Basics and beyond.

An explanation of active learning principles and their adaptation for Large Language Models (LLMs) using human-in-the-loop (HITL) feedback for model alignment, including DPO, GRPO, and RLVR.

An overview of the pharmaceutical industry's history, from 19th-century origins to the current global market size, sales figures, and regional distribution.

An explanation of regulatory requirements for audit trails under 21 CFR Part 11 and EU Annex 11, covering automation strategies, data integrity measures, and the latest 2025-2026 regulatory developments including the Annex 11 draft revision and FDA CSA guidance.

A comprehensive guide to MCP servers for Claude Code web search, including Brave Search, Perplexity Sonar, Bright Data, and Firecrawl. Updated for 2026 with MCP Tool Search, OAuth authentication, and managed configuration.

An explanation of a single source of truth (SSOT) for the pharmaceutical industry. Learn how an SSOT integrates data across the drug lifecycle to ensure consistency.

An analysis of how CRM systems support medical device firms in managing HCP relationships, sales pipelines, and maintaining strict regulatory compliance.

An analysis of AI code assistants in large codebases. Evaluates GitHub Copilot, Amazon Q Developer, Cursor, Claude Code, Tabnine, and others on accuracy, context handling, security, and IDE integration. Updated February 2026.

This report details how pharmaceutical companies use mobile apps for patient support, medication adherence, and data collection, including the 2023-2024 digital therapeutics shakeout, FDA regulatory updates through 2026, and emerging AI-powered engagement strategies.

An overview of Reinforcement Learning (RL) and RLHF. Learn how RL uses reward functions and how RLHF incorporates human judgments to train AI agents. Updated with 2025-2026 developments including DPO, GRPO, DeepSeek-R1, and GPT-5.